Page last updated: 2024-09-04

ter 286 and paclitaxel

ter 286 has been researched along with paclitaxel in 4 studies

Compound Research Comparison

Studies (ter 286)	Trials (ter 286)	Recent Studies (post-2010) (ter 286)	Studies (paclitaxel)	Trials (paclitaxel)	Recent Studies (post-2010) (paclitaxel)
21	7	1	31,874	5,729	15,395

Protein Interaction Comparison

Protein	Taxonomy	paclitaxel (IC50)
Integrin beta-3	Homo sapiens (human)	0.034
Integrin alpha-V	Homo sapiens (human)	0.034
ATP-dependent translocase ABCB1	Homo sapiens (human)	2.598
Botulinum neurotoxin type A	Clostridium botulinum	5.2
UDP-glucuronosyltransferase 2B7	Homo sapiens (human)	4.9
UDP-glucuronosyltransferase 1-6	Homo sapiens (human)	4.9
Substance-K receptor	Homo sapiens (human)	6.125
UDP-glucuronosyltransferase 1A1	Homo sapiens (human)	4.9
UDP-glucuronosyltransferase 1A4	Homo sapiens (human)	4.9
UDP-glucuronosyltransferase 2B10	Homo sapiens (human)	4.9
Delta-type opioid receptor	Homo sapiens (human)	4.202
Tyrosine-protein kinase Mer	Homo sapiens (human)	4.9
Tubulin beta-3 chain	Homo sapiens (human)	0.0082
Beta-tubulin	Leishmania donovani	1
Nucleotide-binding oligomerization domain-containing protein 2	Homo sapiens (human)	7.9433
Solute carrier organic anion transporter family member 1B3	Homo sapiens (human)	0.26
Solute carrier organic anion transporter family member 1B1	Homo sapiens (human)	0.28

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lilenbaum, R; Raez, LE	1
Belt, RJ; Boccia, RV; Brown, GL; Burris, HA; Caldwell, DC; Edelman, MJ; Englund, CW; Fidias, PM; Huberman, MS; Jones, M; Keck, JG; Kolevska, T; Lynch, TJ; Melnyk, O; Meng, L; Mills, GM; Rabin, MS; Sequist, LV; Temel, JS	1
Bast, RC; Brown, GL; Jones, MR; Kavanagh, JJ; Levenback, CF; Meng, L; Moore, CL; Ramirez, PT; Wolf, JL	1

Reviews

2 review(s) available for ter 286 and paclitaxel

Article	Year
Current data and ongoing trials in patients with recurrent non-small-cell lung cancer. Clinical lung cancer, 2004, Volume: 5, Issue:6 Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cytotoxins; Docetaxel; ErbB Receptors; Erlotinib Hydrochloride; Glutamates; Glutathione; Guanine; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Pemetrexed; Prodrugs; Prognosis; Quinazolines; Taxoids	2004
New developments in chemotherapy for advanced non-small cell lung cancer. Current opinion in oncology, 2006, Volume: 18, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Epothilones; Glutamates; Glutathione; Guanine; Humans; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pemetrexed; Pyrazines	2006

Article

Year

Current data and ongoing trials in patients with recurrent non-small-cell lung cancer.

Clinical lung cancer, 2004, Volume: 5, Issue:6

Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cytotoxins; Docetaxel; ErbB Receptors; Erlotinib Hydrochloride; Glutamates; Glutathione; Guanine; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Pemetrexed; Prodrugs; Prognosis; Quinazolines; Taxoids

2004

New developments in chemotherapy for advanced non-small cell lung cancer.

Current opinion in oncology, 2006, Volume: 18, Issue:2

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Epothilones; Glutamates; Glutathione; Guanine; Humans; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pemetrexed; Pyrazines

2006

Trials

2 trial(s) available for ter 286 and paclitaxel

Article	Year
Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cytotoxins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glutathione; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Treatment Outcome	2009
Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer. Journal of hematology & oncology, 2010, Mar-11, Volume: 3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Polyethylene Glycols; Survival Analysis; Treatment Failure	2010

Article

Year

Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:11

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cytotoxins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glutathione; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Treatment Outcome

2009

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer.

Journal of hematology & oncology, 2010, Mar-11, Volume: 3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Polyethylene Glycols; Survival Analysis; Treatment Failure

2010